Eisai (company)
Eisai Co., Ltd. (Japanese: エーザイ株式会社, Hepburn: Ēzai Kabushiki-gaisha) is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices.
Native name | エーザイ株式会社 |
|---|---|
Romanized name | Ēzai kabushiki gaisha |
| Company type | Public KK |
Traded as | TYO: 4523 TOPIX Large 70 Component TOPIX 100 Component Nikkei 225 Component |
| Industry | Pharmaceuticals |
| Founded | December 6, 1941 |
| Founder | Toyoji Naito |
| Headquarters | 4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan |
Key people | Haruo Naito (President and CEO) |
| Products | |
| Revenue | ¥ 680 billion (2019) |
| ¥ 103 billion (2019) | |
Net income | ¥ 72.5 billion (2019) |
| Total assets | ¥ 1,071 billion (2019) |
| Total equity | ¥ 652 billion (2019) |
| Owner | The Master Trust Bank of Japan (11.78%) Japan Trustee Services Bank (10.99%) Nippon Life (4.29%) |
Number of employees | 1,864 (2019) |
| Website | Official website |
| Footnotes / references | |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.